| 1 | TNFRSF25, TNFSF15
|
| Involvement of TL1A and DR3 in induction of ischaemia and inflammation in urinary bladder dysfunction in the elderly.
|
| Wang W, Zhang N, Zhu XH, He ZS, Wahafu W, Xu ZQ, Yang Y.
|
| Mol Med Report 6(2):434-8. doi: 10.3892/mmr.2012.928. Epub 2012 May 25.
2012
|
| 2 | TNFRSF25, TNFSF15, TRADD
|
| The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling.
|
| Pobezinskaya YL, Choksi S, Morgan MJ, Cao X, Liu ZG.
|
| J Immunol 186(9):5212-6. Epub 2011 Mar 18. 2011
|
| 3 | TNFRSF25, TNFSF15
|
| TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
|
| Meylan F, Richard AC, Siegel RM.
|
| Immunol Rev 244(1):188-96. doi: 10.1111/j.1600-065X.2011.01068.x. Review.
2011
|
| 4 | TNFRSF25, TNFSF15
|
| The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.
|
| Meylan F, Song YJ, Fuss I, Villarreal S, Kahle E, Malm IJ, Acharya K, Ramos HL, Lo L, Mentink-Kane MM, Wynn TA, Migone TS, Strober W, Siegel RM.
|
| Mucosal Immunol 4(2):172-85. Epub 2010 Oct 27.
2011
|
| 5 | TNFRSF25, TNFSF15
|
| The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro.
|
| McLaren JE, Calder CJ, McSharry BP, Sexton K, Salter RC, Singh NN, Wilkinson GW, Wang EC, Ramji DP.
|
| J Immunol 184(10):5827-34. Epub 2010 Apr 21.
2010
|
| 6 | CD27, CD70, TNFRSF25, TNFRSF4, TNFRSF9, TNFSF15, TNFSF4, TNFSF9
|
| The role of TNF superfamily members in T-cell function and diseases.
|
| Croft M.
|
| Nat Rev Immunol 9(4):271-85. Review.
2009
|
| 7 | TNFRSF25
|
| Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation.
|
| Fang L, Adkins B, Deyev V, Podack ER.
|
| J Exp Med 205(5):1037-48. Epub 2008 Apr 14.
2008
|
| 8 | CASP10, TNFRSF25
|
| Altered gene expression of caspase-10, death receptor-3 and IGFBP-3 in preeclamptic placentas.
|
| Han JY, Kim YS, Cho GJ, Roh GS, Kim HJ, Choi WJ, Paik WY, Rho GJ, Kang SS, Choi WS.
|
| Mol Cells 22(2):168-74. 2006
|
| 9 | TNFRSF25
|
| Death receptor-3 mediates apoptosis in human osteoblasts under narrowly regulated conditions.
|
| Borysenko CW, García-Palacios V, Griswold RD, Li Y, Iyer AK, Yaroslavskiy BB, Sharrow AC, Blair HC.
|
| J Cell Physiol 209(3):1021-8.
2006
|
| 10 | TNFRSF25
|
| Comparative modeling of TNFRSF25 (DR3) predicts receptor destabilization by a mutation linked to rheumatoid arthritis.
|
| Borysenko CW, Furey WF, Blair HC.
|
| Biochem Biophys Res Commun 328(3):794-9. 2005
|
| 11 | TNFRSF25, TNFSF15
|
| Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis.
|
| Kang YJ, Kim WJ, Bae HU, Kim DI, Park YB, Park JE, Kwon BS, Lee WH.
|
| Cytokine 29(5):229-35. 2005
|
| 12 | TNFRSF25
|
| Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis.
|
| Osawa K, Takami N, Shiozawa K, Hashiramoto A, Shiozawa S.
|
| Genes Immun 5(6):439-43.
2004
|
| 13 | TNFRSF25
|
| Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants.
|
| Al-Lamki RS, Wang J, Thiru S, Pritchard NR, Bradley JA, Pober JS, Bradley JR.
|
| Am J Pathol 163(2):401-11.
2003
|
| 14 | TNFRSF25
|
| Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system.
|
| Eggert A, Grotzer MA, Zuzak TJ, Ikegaki N, Zhao H, Brodeur GM.
|
| Eur J Cancer 38(1):92-8. 2002
|
| 15 | TNFRSF25
|
| A new death receptor 3 isoform: expression in human lymphoid cell lines and non-Hodgkin's lymphomas.
|
| Warzocha K, Ribeiro P, Charlot C, Renard N, Coiffier B, Salles G.
|
| Biochem Biophys Res Commun 242(2):376-9. 1998
|
| 16 | TNFRSF25
|
| TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95).
|
| Bodmer JL, et al.
|
| Immunity 6 : 79-88. 1997
|
| 17 | TNFRSF25
|
| LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing.
|
| Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, McMichael AJ, Bell JI.
|
| Proc Natl Acad Sci U S A 94(9):4615-9. 1997
|
| 18 | TNFRSF25
|
| Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B.
|
| Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A.
|
| Curr Biol 6(12):1669-76. 1996
|
| 19 | TNFRSF25
|
| Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95.
|
| Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM.
|
| Science 274(5289):990-2. 1996
|
| 20 | TNFRSF25
|
| A death-domain-containing receptor that mediates apoptosis.
|
| Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, Grinham CJ, Brown R, Farrow SN.
|
| Nature 384(6607):372-5. 1996
|